Quick Answer
10x Genomics, Inc. reported Net Income Loss of -$43.54 million for the year ending 2025.
- 10x Genomics, Inc. showed an increase of +76.2% in Net Income Loss from 2024 to 2025.
- This data is from 10x Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), 10x Genomics, Inc.'s Net Income Loss has declined by 132.1%.
- Historical annual values: Fiscal year 2025: -$43.54 million | Fiscal year 2024: -$182.63 million | Fiscal year 2023: -$255.10 million | Fiscal year 2022: -$166.00 million | Fiscal year 2021: -$58.22 million | Fiscal year 2020: -$542.73 million | Fiscal year 2019: -$31.25 million | Fiscal year 2018: -$112.49 million | Fiscal year 2017: -$18.76 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: